The FAA administrator's comments come on the eve of his visit to Boeing facilities outside Seattle, Washington. While there, he's scheduled to meet with Boeing executives and...Airlinesread more
Investors largely expected the FOMC to cut rates by a quarter point.The Fedread more
As the Fed was meeting to consider cutting interest rates, it lost control of the very benchmark rate that it manages.Market Insiderread more
Federal Reserve Chairman Jerome Powell said the he does not see the Fed using negative interest rates in the future.The Fedread more
President Barack Obama spoke at an event in San Francisco on Wednesday hosted by software company Splunk and addressed how tech can help solve problems.Technologyread more
The decision to cut rates followed a monthslong pressure campaign by Trump, who often criticized Chairman Jerome Powell by name as he called for lower interest rates.Politicsread more
On Instagram and other social media sites, health misinformation is rampant. Companies have only recently begun to take steps to clamp down on this kind of content.Technologyread more
Steve Dowling, the head of Apple's public relations department, announced he will be leaving this week.Technologyread more
Tracy Britt Cool is leaving the firm after a decade to start a company that replicates Warren Buffett's business model, the Wall Street Journal reported.Marketsread more
Stocks closed little changed after the Federal Reserve failed to signal it will cut rates again in 2019, disappointing traders.US Marketsread more
A federal judge cited new evidence of potential terrorism sympathies Wednesday in denying bail for a longtime mechanic charged with sabotaging an American Airlines jetliner...Transportationread more
Sept 9 (Reuters) - The U.S. judge overseeing nationwide litigation concerning the opioid crisis on Monday rejected Purdue Pharma LP's effort to dismiss claims that its activities caused a public nuisance.
U.S. District Judge Dan Polster in Cleveland said a reasonable jury could conclude that Purdue's alleged fraudulent marketing of opioids, for the purpose of increasing sales, caused a nuisance.
Polster's decision came six weeks before the scheduled Oct. 21 trial on the impact of opioids on two Ohio counties. The outcome could affect some 2,000 other opioid lawsuits by various municipalities and entities.
Separately, Polster rejected efforts by drug distributors and pharmacies to exclude testimony from an economist who believes the counties, Cuyahoga and Summit, suffered between $194.4 million and $223.4 million of damages from 2006 to 2018.
Purdue is expected to file for bankruptcy after settlement talks stalled, the Associated Press reported on Saturday, citing state attorneys general involved in the talks. A bankruptcy filing would likely remove Purdue from the trial. (Reporting by Jonathan Stempel in New York; Editing by David Gregorio)